镰状细胞病儿童人群的维生素D缺乏症

IF 1.2 4区 医学 Q4 HEMATOLOGY Pediatric Hematology and Oncology Pub Date : 2025-01-17 DOI:10.1080/08880018.2025.2451843
Thiago de Souza Vilela, Mauro Fisberg, Gerson Ferrari, Josefina Aparecida Pellegrini Braga
{"title":"镰状细胞病儿童人群的维生素D缺乏症","authors":"Thiago de Souza Vilela, Mauro Fisberg, Gerson Ferrari, Josefina Aparecida Pellegrini Braga","doi":"10.1080/08880018.2025.2451843","DOIUrl":null,"url":null,"abstract":"<p><p>Pediatric patients with sickle cell disease and vitamin D deficiency have worse clinical and laboratory outcomes. This study aims to quantify the prevalence of vitamin D deficiency in this population and identify possible risk factors for hypovitaminosis D by performing a cross-sectional study with children aged 3-18 years old with sickle cell disease. Sixty patients were evaluated, with a mean age of 10.80 + 4.21 years. The prevalence of vitamin D deficiency was 46.7% (21.02 ± 8.47 ng/mL). Patients were clustered into two groups regarding vitamin D deficiency (25-OH-<i>D</i> < 20 ng/mL). When comparing groups with and without vitamin D deficiency, age (<i>p</i> = 0.002) and season of 25-OH-D collection (<i>p</i> = 0.005) were statistically significant. Age presented OR 1.23 (95% CI: 1.07; 1.41/<i>p</i> = 0.004), as well as the season of the 25-OH-D collection with OR 5.21 (95% CI: 1.58; 17.14/<i>p</i> = 0.007) for autumn/winter assessment. After linear regression, an association was noted for age (<i>β</i> = -0.80/95% CI: -1.29; -0.320/<i>p</i> = 0.002), days of sun exposure (<i>β</i> = 0.83/95% CI: 0.07; 1.58/<i>p</i> = 0.032), and autumn/winter vitamin D assessment (<i>β</i> = -7.94/95% CI: -12.02; -3.85/<i>p</i> = 0.032). In conclusion, hypovitaminosis D is highly prevalent in this population; meanwhile, age, season of 25-OH-D collection, and days of sunlight exposure appeared as risk factors for deficiency.</p>","PeriodicalId":19746,"journal":{"name":"Pediatric Hematology and Oncology","volume":" ","pages":"1-12"},"PeriodicalIF":1.2000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vitamin D deficiency in a pediatric population with sickle cell disease.\",\"authors\":\"Thiago de Souza Vilela, Mauro Fisberg, Gerson Ferrari, Josefina Aparecida Pellegrini Braga\",\"doi\":\"10.1080/08880018.2025.2451843\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Pediatric patients with sickle cell disease and vitamin D deficiency have worse clinical and laboratory outcomes. This study aims to quantify the prevalence of vitamin D deficiency in this population and identify possible risk factors for hypovitaminosis D by performing a cross-sectional study with children aged 3-18 years old with sickle cell disease. Sixty patients were evaluated, with a mean age of 10.80 + 4.21 years. The prevalence of vitamin D deficiency was 46.7% (21.02 ± 8.47 ng/mL). Patients were clustered into two groups regarding vitamin D deficiency (25-OH-<i>D</i> < 20 ng/mL). When comparing groups with and without vitamin D deficiency, age (<i>p</i> = 0.002) and season of 25-OH-D collection (<i>p</i> = 0.005) were statistically significant. Age presented OR 1.23 (95% CI: 1.07; 1.41/<i>p</i> = 0.004), as well as the season of the 25-OH-D collection with OR 5.21 (95% CI: 1.58; 17.14/<i>p</i> = 0.007) for autumn/winter assessment. After linear regression, an association was noted for age (<i>β</i> = -0.80/95% CI: -1.29; -0.320/<i>p</i> = 0.002), days of sun exposure (<i>β</i> = 0.83/95% CI: 0.07; 1.58/<i>p</i> = 0.032), and autumn/winter vitamin D assessment (<i>β</i> = -7.94/95% CI: -12.02; -3.85/<i>p</i> = 0.032). In conclusion, hypovitaminosis D is highly prevalent in this population; meanwhile, age, season of 25-OH-D collection, and days of sunlight exposure appeared as risk factors for deficiency.</p>\",\"PeriodicalId\":19746,\"journal\":{\"name\":\"Pediatric Hematology and Oncology\",\"volume\":\" \",\"pages\":\"1-12\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Hematology and Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/08880018.2025.2451843\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Hematology and Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08880018.2025.2451843","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

患有镰状细胞病和维生素D缺乏症的儿科患者的临床和实验室结果更差。本研究旨在量化这一人群中维生素D缺乏症的患病率,并通过对3-18岁镰状细胞病儿童进行横断面研究,确定维生素D缺乏症的可能危险因素。60例患者接受评估,平均年龄10.80 + 4.21岁。维生素D缺乏症发生率为46.7%(21.02±8.47 ng/mL)。维生素D缺乏症患者分为两组(25-OH-D p = 0.002),收集25-OH-D的季节(p = 0.005)有统计学意义。年龄呈现OR为1.23 (95% CI: 1.07;1.41/p = 0.004),以及25-OH-D采集的季节,OR为5.21 (95% CI: 1.58;17.14/p = 0.007)进行秋冬评估。线性回归后,发现年龄有相关性(β = -0.80/95% CI: -1.29;-0.320 / p = 0.002),天的日晒(β= 0.83 / 95% CI: 0.07;1.58/p = 0.032),秋季/冬季维生素D评估(β = -7.94/95% CI: -12.02;-3.85/p = 0.032)。总之,维生素D缺乏症在这一人群中非常普遍;年龄、采集25-OH-D的季节和日照天数是维生素d缺乏的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Vitamin D deficiency in a pediatric population with sickle cell disease.

Pediatric patients with sickle cell disease and vitamin D deficiency have worse clinical and laboratory outcomes. This study aims to quantify the prevalence of vitamin D deficiency in this population and identify possible risk factors for hypovitaminosis D by performing a cross-sectional study with children aged 3-18 years old with sickle cell disease. Sixty patients were evaluated, with a mean age of 10.80 + 4.21 years. The prevalence of vitamin D deficiency was 46.7% (21.02 ± 8.47 ng/mL). Patients were clustered into two groups regarding vitamin D deficiency (25-OH-D < 20 ng/mL). When comparing groups with and without vitamin D deficiency, age (p = 0.002) and season of 25-OH-D collection (p = 0.005) were statistically significant. Age presented OR 1.23 (95% CI: 1.07; 1.41/p = 0.004), as well as the season of the 25-OH-D collection with OR 5.21 (95% CI: 1.58; 17.14/p = 0.007) for autumn/winter assessment. After linear regression, an association was noted for age (β = -0.80/95% CI: -1.29; -0.320/p = 0.002), days of sun exposure (β = 0.83/95% CI: 0.07; 1.58/p = 0.032), and autumn/winter vitamin D assessment (β = -7.94/95% CI: -12.02; -3.85/p = 0.032). In conclusion, hypovitaminosis D is highly prevalent in this population; meanwhile, age, season of 25-OH-D collection, and days of sunlight exposure appeared as risk factors for deficiency.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.60
自引率
5.90%
发文量
71
审稿时长
6-12 weeks
期刊介绍: PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.
期刊最新文献
Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers. Long-Term Survey of Japanese Children with Recurrent Nephroblastoma: A Report from Japan Children's Cancer Group. Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma? Impact of socioeconomic factors on time to diagnosis of childhood cancer. Current approaches in development and implementation of medical education strategies among pediatric hematology/oncology fellowship programs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1